Schneider U - Search Results

1

Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial.

Schleussner E, Lehmann T, Kähler C, Schneider U, Schlembach D, Groten T. Schleussner E, et al. Among authors: schneider u. J Perinat Med. 2014 Jul;42(4):507-14. doi: 10.1515/jpm-2013-0212. J Perinat Med. 2014. PMID: 24421214 Clinical Trial.

2

Erratum to: Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial.

Schleussner E, Lehmann T, Kähler C, Schneider U, Schlembach D, Groten T. Schleussner E, et al. Among authors: schneider u. J Perinat Med. 2015 Sep;43(5):641. doi: 10.1515/jpm-2015-0262. J Perinat Med. 2015. PMID: 26353164

3

Pentaerythrityltetranitrate (PETN) improves utero- and feto-placental Doppler parameters in pregnancies with impaired utero-placental perfusion in mid-gestation - a secondary analysis of the PETN-pilot trial.

Bowkalow S, Schleussner E, Kähler C, Schneider U, Lehmann T, Groten T. Bowkalow S, et al. Among authors: schneider u. J Perinat Med. 2018 Nov 27;46(9):1004-1009. doi: 10.1515/jpm-2017-0238. J Perinat Med. 2018. PMID: 29272253 Clinical Trial.

4

OS013. Reduction of preeclampsia related complications with with theNO-donor penterythriltetranitrat (petn) in risk pregnancies - Aprospective randomized double-blind placebo pilot study.

Groten T, Fitzgerald J, Lehmann T, Schneider U, Kähler C, Schleussner E. Groten T, et al. Among authors: schneider u. Pregnancy Hypertens. 2012 Jul;2(3):181. doi: 10.1016/j.preghy.2012.04.014. Epub 2012 Jun 13. Pregnancy Hypertens. 2012. PMID: 26105227

5

Fetal heart rate variability in growth restricted fetuses.

Schneider U, Fiedler A, Liehr M, Kähler C, Schleussner E. Schneider U, et al. Biomed Tech (Berl). 2006 Oct;51(4):248-50. doi: 10.1515/BMT.2006.048. Biomed Tech (Berl). 2006. PMID: 17061950

6

Human fetal heart rate variability-characteristics of autonomic regulation in the third trimester of gestation.

Schneider U, Frank B, Fiedler A, Kaehler C, Hoyer D, Liehr M, Haueisen J, Schleussner E. Schneider U, et al. J Perinat Med. 2008;36(5):433-41. doi: 10.1515/JPM.2008.059. J Perinat Med. 2008. PMID: 18605969

7

Developmental changes of auditory-evoked fields in fetuses.

Schleussner E, Schneider U. Schleussner E, et al. Among authors: schneider u. Exp Neurol. 2004 Nov;190 Suppl 1:S59-64. doi: 10.1016/j.expneurol.2004.04.008. Exp Neurol. 2004. PMID: 15498543 Clinical Trial.

8

Fetal magnetocardiography: development of the fetal cardiac time intervals.

Kähler C, Schleussner E, Grimm B, Schneider A, Schneider U, Nowak H, Seewald HJ. Kähler C, et al. Among authors: schneider u, schneider a. Prenat Diagn. 2002 May;22(5):408-14. doi: 10.1002/pd.322. Prenat Diagn. 2002. PMID: 12001197

9

Influence of intrauterine growth restriction on cardiac time intervals evaluated by fetal magnetocardiography.

Grimm B, Kaehler C, Schleussner E, Schneider U, Haueisen J, Seewald HJ. Grimm B, et al. Among authors: schneider u. Early Hum Dev. 2003 Oct;74(1):1-11. doi: 10.1016/s0378-3782(03)00079-3. Early Hum Dev. 2003. PMID: 14512177

10

Prenatal diagnosis of a long QT syndrome by fetal magnetocardiography in an unshielded bedside environment.

Schneider U, Haueisen J, Loeff M, Bondarenko N, Schleussner E. Schneider U, et al. Prenat Diagn. 2005 Aug;25(8):704-8. doi: 10.1002/pd.1205. Prenat Diagn. 2005. PMID: 16052576

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,113 results

Search Page

Filters